Clinical trial
Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III
NCT00172380 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00172380 |
|---|---|
| Title | Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III |
| Official title | Phase II Study Evaluating Docetaxel and CDDP as Neoadjuvant Chemotherapy Prior to Surgery, Followed by Adjuvant Docetaxel Plus CDDP in Chemonaive Patients With NSCLC Stage III |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | NSCLC |
| Intervention type | Drug |
| Interventions | Docetaxel Plus CDDP |
| Enrollment | 41 |
| Start date | Feb 1, 2005 |
| Primary completion | Jan 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 20, 2012 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: